课题基金 / 基金详情

Study on molecular mechanism underlying genomic susceptibility to congenital hypomyelinating leukodystrophy

Study on molecular mechanism underlying genomic susceptibility to congenital hypomyelinating leukodystrophy
先天性低髓鞘性脑白质营养不良基因组易感性分子机制研究
批准号:
23659531
负责人:
INOUE Ken
金额:
$2.33万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012

项目摘要

项目成果

INOUE Ken的其他基金

相似基金

相关文献

中文摘要
翻译
Pelizaeus-Merzbacher病(PMD)是一种以中枢神经系统髓鞘功能减退为特征的遗传性顽固性疾病。含有PLP1基因的基因组重复是PMD最常见的原因。然而,为什么重复是PMD最常见的原因尚不清楚。我们推测,可能存在一种基因组结构特征,使该基因组区域易于发生基因组重排。我们通过应用大量来自PLP1重复患者的DNA样本进行高分辨率基因组分析来验证这一假设,以描绘导致PLP1重复的异常基因组重排的分子机制。我们设计了一种针对PLP1基因组区域的高分辨率定制计算全息阵列,并分析了70例存在重复的PMD病例。我们在所有病例中都证实了涉及PLP1的基因组复制。复制的线段在长度和区域上各不相同。在近端和远端的断裂点中都没有发现共同的断裂点,尽管远端的断裂点倾向于聚集在几千kb的区域内,这些区域富含节段重复。我们还发现,在某些情况下,单拷贝或三拷贝片段中断了复制,这表明了基因组重排背后的复杂机制。我们正在核苷酸水平上检测这些案例中的重组连接片段。
英文摘要
Pelizaeus-Merzbacher disease (PMD) is inherited intractable disorder characterized by hypomyelination of central nervous system. Genomic duplication containing PLP1 gene is the most common cause of PMD. However, it is unknown as to why duplication is the most common cause of PMD. We hypothesized that there may be a genomic structural feature that predispose this genomic region for susceptibility of genomic rearrangement. We tested this hypothesis by applying numerous DNA samples from PLP1 duplication patients for high-resolution genomic analysis to delineate molecular mechanism underlying the abnormal genomic rearrangement resulting in PLP1 duplication. We designed a high-resolution custom CGH array specific to the PLP1 genomic region and analyzed 70 PMD cases with duplication. We confirmed genomic duplications involving PLP1 in all cases. Duplicated segments vary in length and region. No common breakpoint was found in either proximal or distal breakpoints, although distal breakpoints tend to cluster within a few thousands kb region enriched with segmental duplication. We also found interruption of duplication by single copy or triplicated copy segments in some cases, indicating a complex mechanism underlying genomic rearrangement. We are examining the recombination junction fragments in these cases at the nucleotide level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Treating Pelizaeus-Merzbacher disease with clinically applicable compounds, curumin and chloroquine: preclinical studies
用临床适用的化合物、姜黄素和氯喹治疗 Pelizaeus-Merzbacher 病:临床前研究
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Ken Inoue, Toshifumi Morimura, Yurika Numata, Li-Hua Yu, Leo Gotoh, Ryoko Yamamoto, Naoko Inoue, Barbara Antalfy, Kimiko Deguchi, Hitoshi Osaka, Yu-ichi Goto]
通讯作者: Yu-ichi Goto
Pelizaeus-Merzbacher 病の治療法開発への試み
尝试开发 Pelizaeus-Merzbacher 病的治疗方法
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [井上 健, 守村敏史, 沼田有里佳, Li-Hua Yu, 後藤玲央, 山本良子, 井上直子, 出 口貴美子, 小坂 仁, 後藤雄一]
通讯作者: 後藤雄一
軽症型Pelizaeus-Merzbacher 病の分子病態:患者の皮膚由来の線維芽細胞、iPS 細胞による病態解析
轻度 Pelizaeus-Merzbacher 病的分子病理学:使用患者皮肤来源的成纤维细胞和 iPS 细胞进行病理分析
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [沼田 有里佳, 涌澤 圭介, 植松 貢, 大 沼 晃, 後藤 雄一, 井上 健]
通讯作者: 井上 健
超早産児の虚血性脳傷害モデルマウスを用いた解析;第3報
使用极早产儿缺血性脑损伤小鼠模型进行分析;第三份报告
DOI: --
发表时间:
期刊:
影响因子: --
作者: [Fukuda, A., et al, 出口貴美子 他]
通讯作者: 出口貴美子 他
共 35 条
    Effective suicide measures among younger age group by the cooperation with medicine and administration
    • 批准号:
      17K09194
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      INOUE Ken
    • 依托单位:
    The mechanisms of intestinal fibrosis and strictures associated with upregulation of NADPH oxidase 4 and reactive oxygen species
    • 批准号:
      25860553
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      INOUE Ken
    • 依托单位:
    Economic analysis on relation between fishermen's altruistic behavior and local heterogeneity
    • 批准号:
      24530242
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.66万
    • 财政年份:
      2012
    • 负责人:
      INOUE Ken
    • 依托单位:
    Molecular basis for the complex neurocristopathy PCWH and mechanisms underlying SOX10 allelic affinity
    海外基金